Spruce Biosciences, Inc. (SPRB) Operating margin 2023–2024
Spruce Biosciences, Inc. (SPRB) operating margin by fiscal year — reported operating income divided by reported revenue.
-1143.4%FY2024 · since FY2023: -515.3% → -1143.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1143.4% | -628.0 pp |
| FY2023 | -515.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net incomeSPRB Net marginSPRB Gross profitSPRB Gross marginSPRB Operating incomeSPRB Operating cash flowSPRB Free cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Total liabilitiesSPRB Shareholders’ equitySPRB overview →